| CAS: | 1135280-28-2 | ||
| 分子式: | C24H28ClN2O7PS | ||
| 分子量: | 554.98 | ||
| 英文名称: |
| ||
| 用途: | KN-92 phosphate 是KN-93的非活性衍生物。KN-93是钙离子/钙调蛋白依赖激酶II(CaMKII)抑制剂,能竞争性阻断钙调蛋白与对应激酶的结合,Ki为370 nM。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||
| K884444 | MACKLIN | KN-92 phosphate | ≥99% | 205元/5mg; 438元/25mg; 1314元/100mg; | 展开 | ||||||||||||||||||||||||||||||
储存:2-8℃ | |||||||||||||||||||||||||||||||||||
| K797719 | MACKLIN | KN-92 phosphate | 10mM in DMSO | 620元/1ml; | 展开 | ||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||
| 422709 | Sigma-Aldrich | KN-92-CAS 1135280-28-2-Calbiochem | KN-92, CAS 1135280-28-2, is useful as a negative control for KN-93 (Cat. No. 422708), a Ca2+/CaM Kinase II inhibitor. | 2340.22元/1 MG; | 展开 | ||||||||||||||||||||||||||||||
产品说明 一般描述 Useful as a negative control for KN-93 (Cat. No. 422708), a Ca2+/CaM kinase II inhibitor. Also available as a 5 mM solution in DMSO (Cat. No. 508314). 包装 1 mg in Glass bottle 生化/生理作用 Cell permeable: yes 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 4 months at -20°C. 其他说明 Fan, G.H., et al. 1999. Mol. Pharmacol.56, 39. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||
| 5.08314 | Sigma-Aldrich | InSolution KN-92-CAS 1135280-28-2-Calbiochem | 941.43元/500 μG; | 展开 | |||||||||||||||||||||||||||||||
产品说明 一般描述 Useful as a negative control for KN-93 (Cat. No. 422708), a Ca2+/CaM kinase II inhibitor. 生化/生理作用 Cell permeable: yes 包装 Packaged under inert gas 警告 Toxicity: Standard Handling (A) 外形 A 5 mM (500 µg/180 µL) sterile-filtered solution of KN-92 (Cat. No. 422709) in DMSO. 重悬 Following initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 3 months at -20°C. 其他说明 Fan, G.H., et al. 1999. Mol. Pharmacol.56, 39. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||